MD Logo

MEDNAX Inc (MD) Stock Forecast & Price Prediction

Live MD Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NYSE | Healthcare | Medical Care Facilities

$14.05

-0.42 (-2.90%)

12 Month Price Forecast For MD

$14.05
Current Price
$1.23B
Market Cap
8 Ratings
Buy 3
Hold 5
Sell 0
Wall St Analyst Ratings

Distance to MD Price Forecasts

+35.2%
To High Target of $19.00
+13.9%
To Median Target of $16.00
+6.8%
To Low Target of $15.00

MD Price Momentum

+3.1%
1 Week Change
+0.4%
1 Month Change
+50.1%
1 Year Change
+7.1%
Year-to-Date Change
-14.4%
From 52W High of $16.41
+112.2%
From 52W Low of $6.62

๐Ÿค” Considering MEDNAX (MD)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 15, 2025 4:04 AM UTC

MD Analyst Ratings & Price Targets

Based on our analysis of 18 Wall Street analysts, MD has a neutral consensus with a median price target of $16.00 (ranging from $15.00 to $19.00). The overall analyst rating is Buy (7.5/10). Currently trading at $14.05, the median forecast implies a 13.9% upside. This outlook is supported by 3 Buy, 5 Hold, and 0 Sell ratings.

Conversely, the most conservative target is provided by David Macdonald at Truist Securities, suggesting a 6.8% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

MD Analyst Consensus

3
Buy
5
Hold
0
Sell

MD Price Target Range

Low
$15.00
Average
$16.00
High
$19.00
Current: $14.05

Latest MD Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for MD.

Date Firm Analyst Rating Change Price Target
Jan 6, 2025 Truist Securities David Macdonald Hold Maintains $15.00
Dec 16, 2024 Macquarie Tao Qiu Outperform Initiates $18.00
Nov 19, 2024 Mizuho Ann Hynes Neutral Maintains $15.00
Nov 5, 2024 Jefferies Jack Slevin Buy Maintains $18.00
Nov 5, 2024 UBS A.J. Rice Neutral Maintains $16.50
Nov 4, 2024 Deutsche Bank Pito Chickering Hold Maintains $15.00
Nov 4, 2024 Truist Securities David Macdonald Hold Maintains $16.00
Nov 4, 2024 Mizuho Ann Hynes Neutral Maintains $15.00
Oct 7, 2024 Truist Securities David Macdonald Hold Maintains $13.00
Sep 26, 2024 Jefferies Jack Slevin Buy Upgrade $14.00
Aug 15, 2024 Truist Securities David Macdonald Hold Maintains $10.00
Aug 9, 2024 UBS A.J. Rice Neutral Maintains $10.50
Jul 15, 2024 Truist Securities David Macdonald Hold Maintains $8.00
Jun 7, 2024 Deutsche Bank Pito Chickering Hold Upgrade $8.00
May 15, 2024 Truist Securities David Macdonald Hold Maintains $10.00
Mar 6, 2024 Jefferies Brian Tanquilut Hold Maintains $9.00
Feb 21, 2024 Truist Securities David Macdonald Hold Maintains $10.00
Feb 21, 2024 Mizuho Ann Hynes Neutral Maintains $9.00
Nov 30, 2023 UBS A.J. Rice Neutral Initiates $9.50
Oct 11, 2023 Truist Securities David Macdonald Hold Maintains $15.00

Stocks Similar to MEDNAX Inc

The following stocks are similar to MEDNAX based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

MEDNAX Inc (MD) Financial Data

MEDNAX Inc has a market capitalization of $1.23B with a P/E ratio of 8.0x. The company generates $2.01B in trailing twelve-month revenue with a -12.6% profit margin.

Revenue growth is +0.9% quarter-over-quarter, while maintaining an operating margin of +10.3% and return on equity of -29.9%.

Valuation Metrics

Market Cap $1.23B
Enterprise Value $1.67B
P/E Ratio 8.0x
PEG Ratio 9.4x
Price/Sales 0.6x

Growth & Margins

Revenue Growth (YoY) +0.9%
Gross Margin +22.9%
Operating Margin +10.3%
Net Margin -12.6%
EPS Growth -9.1%

Financial Health

Cash/Price Ratio +18.6%
Current Ratio 1.4x
Debt/Equity 93.3x
ROE -29.9%
ROA +4.7%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

MEDNAX Inc logo

MEDNAX Inc (MD) Company Overview

About MEDNAX Inc

What They Do

Provides specialized pediatric and maternal-fetal care.

Business Model

The company operates a network of healthcare providers that deliver specialized care services for newborns, expectant mothers, and pediatric patients. It generates revenue primarily through hospital contracts and billing for clinical services provided by its affiliated medical professionals, including pediatric subspecialists and maternal-fetal medicine experts.

Additional Information

Founded in 1979 and based in Sunrise, Florida, the company previously operated under the name MEDNAX, Inc. It offers a wide range of pediatric subspecialty services and has a strong presence in hospital settings, focusing on areas such as neonatal care and pediatric cardiology, which positions it to benefit from ongoing healthcare demands in maternal and child services.

Company Information

Sector

Healthcare

Industry

Medical Care Facilities

Employees

5,450

CEO

Mr. Mark S. Ordan

Country

United States

IPO Year

1995

MEDNAX Inc (MD) Latest News & Analysis

MD stock latest news image
Quick Summary

NEO: The Conference for Neonatology, focused on advancing neonatology education, is taking place in Fort Lauderdale, Florida.

Why It Matters

The NEO Conference highlights advancements in neonatology, potentially driving innovation and investment opportunities in healthcare, particularly for companies involved in neonatal care solutions.

Source: Business Wire
Market Sentiment: Neutral
MD stock latest news image
Quick Summary

Pediatrix Medical Group has scheduled its 2024 Fourth Quarter Conference Call/Webcast for February 20, 2025.

Why It Matters

The scheduled conference call for Pediatrix Medical Group may indicate upcoming financial performance insights, impacting stock valuation and investor sentiment.

Source: Business Wire
Market Sentiment: Neutral
MD stock latest news image
Quick Summary

Pediatrix announced strategic initiatives aimed at enhancing shareholder value, according to a Business Wire report from Fort Lauderdale, Fla.

Why It Matters

Pediatrix's strategic initiatives signal potential growth and improved profitability, likely boosting shareholder confidence and stock performance.

Source: Business Wire
Market Sentiment: Neutral
MD stock latest news image
Quick Summary

Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR) are two Medical Services stocks that may appeal to value investors.

Why It Matters

The comparison of Pediatrix Medical Group and Avantor highlights potential investment opportunities, guiding value investors in making informed decisions based on relative attractiveness.

Source: Zacks Investment Research
Market Sentiment: Positive
MD stock latest news image
Quick Summary

Zacks Style Scores help investors identify top-rated stocks tailored to their investing style, providing a streamlined approach for stock selection.

Why It Matters

Zacks Style Scores can help investors identify high-potential stocks tailored to their strategies, enhancing decision-making and potentially improving returns.

Source: Zacks Investment Research
Market Sentiment: Positive
MD stock latest news image
Quick Summary

MD is expected to experience future growth due to stable same-facility patient volume, inorganic initiatives, and a shift to a revenue cycle management structure.

Why It Matters

Stable patient volume growth and strategic initiatives indicate potential for revenue increase and operational efficiency, signaling positive future performance for MD.

Source: Zacks Investment Research
Market Sentiment: Positive

Frequently Asked Questions About MD Stock

What is MEDNAX Inc's (MD) stock forecast for 2025?

Based on our analysis of 18 Wall Street analysts, MEDNAX Inc (MD) has a median price target of $16.00. The highest price target is $19.00 and the lowest is $15.00.

Is MD stock a good investment in 2025?

According to current analyst ratings, MD has 3 Buy ratings, 5 Hold ratings, and 0 Sell ratings. The stock is currently trading at $14.05. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for MD stock?

Wall Street analysts predict MD stock could reach $16.00 in the next 12 months. This represents a 13.9% increase from the current price of $14.05. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is MEDNAX Inc's business model?

The company operates a network of healthcare providers that deliver specialized care services for newborns, expectant mothers, and pediatric patients. It generates revenue primarily through hospital contracts and billing for clinical services provided by its affiliated medical professionals, including pediatric subspecialists and maternal-fetal medicine experts.

What is the highest forecasted price for MD MEDNAX Inc?

The highest price target for MD is $19.00 from at , which represents a 35.2% increase from the current price of $14.05.

What is the lowest forecasted price for MD MEDNAX Inc?

The lowest price target for MD is $15.00 from David Macdonald at Truist Securities, which represents a 6.8% increase from the current price of $14.05.

What is the overall MD consensus from analysts for MEDNAX Inc?

The overall analyst consensus for MD is neutral. Out of 18 Wall Street analysts, 3 rate it as Buy, 5 as Hold, and 0 as Sell, with a median price target of $16.00.

How accurate are MD stock price projections?

Stock price projections, including those for MEDNAX Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.